English 
Spanish 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi 开放获取期刊获得更多读者和引用
700 种期刊 和 15,000,000 名读者 每份期刊 获得 25,000 多名读者
索引于
- CAS 来源索引 (CASSI)
- 哥白尼索引
- 谷歌学术
- 夏尔巴·罗密欧
- 打开 J 门
- 学术钥匙
- 参考搜索
- 哈姆达大学
- 亚利桑那州EBSCO
- OCLC-世界猫
- 普布隆斯
- 欧洲酒吧
- ICMJE
有用的链接
开放获取期刊
分享此页面
抽象的
HER2-Targeted Antibody Treatment for Ovarian Cancer Future Opportunities
Simon P Langdon, Andrew H Sims
There are an estimated 240,000 new cases of ovarian cancer diagnosed worldwide each year. Due to late presentation, in many parts of the world it remains the most lethal gynecological cancer. In 2004, a new model description of this disease was proposed that combined both histopathological and molecular features and which classified epithelial ovarian cancers into two broad categories designated Type I and Type II tumors.
免责声明: 此摘要通过人工智能工具翻译，尚未经过审核或验证。